Qvin
YC W16San Francisco, US · Founded 2014 · 30 employees · 2 known investors
Qvin develops the Q-Pad, an FDA-cleared diagnostic menstrual pad that collects menstrual blood samples for non-invasive health monitoring and disease diagnosis. The company uses biomarker analysis from menstrual fluid to serve healthcare organizations and diagnostic platforms in women's health diagnostics.
Digital HealthFemTechHealthtechMedical DevicesWellness & FitnessAI-powered Drug DiscoveryConsumer Health ServicesTelemedicinein /qvin/@weareqvin
Founders & leadership· Y Combinator alumni (W16)
Investors · 2
In the news
- Issue 35: Qvin's world-first diagnostic period pad | $8.5m for Annabella pump | $3m for Health in her HUEfuturefemhealth.com · 2024
- This Pad Aims to Monitor A1C Levels Via Menstrual Blood – WWDwwd.com · 2024
- Qvin’s Q-Pad Makes History with First FDA Approval for Menstrual Blood Health Testingfemtechinsider.com · 2024
- Qvin - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Qvin - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021